HealthCare Global Enterprises Limited (NSE:HCG)
India flag India · Delayed Price · Currency is INR
730.45
-14.80 (-1.99%)
Aug 20, 2026, 3:30 PM IST

NSE:HCG Cash Flow Statement

Millions INR. Fiscal year is Apr - Mar.

Operating Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Net Income
137.6444.1481.55293.49537.33
Depreciation & Amortization
2,4422,0571,6911,5441,473
Other Amortization
-56.8652.9290.85109.43
Loss (Gain) From Sale of Assets
-2.510.6417.7413.226.43
Asset Writedown & Restructuring Costs
319.1---472.45
Loss (Gain) From Sale of Investments
-0.6-1.57-2.17-0.35-1,500
Loss (Gain) on Equity Investments
-14.6-7.76-3.880.1814.25
Stock-Based Compensation
-566.465.4478.4665.1431.03
Provision & Write-off of Bad Debts
218.5204.24229.93163.02150.63
Other Operating Activities
1,3641,108572.48805.161,012
Change in Accounts Receivable
-425.1-907.51-278.17-785.48-404.4
Change in Inventory
-93.8-96.13-39.51-83.14-60.75
Change in Accounts Payable
21.1295.199.38563.47442.92
Change in Other Net Operating Assets
72.4-56.42-53.58-153.53-82.97
Operating Cash Flow
3,4713,1712,8462,5162,201
Operating Cash Flow Growth
9.46%11.43%13.11%14.29%82.64%

Investing Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Capital Expenditures
-2,921-2,089-1,857-1,332-712.32
Sale of Property, Plant & Equipment
36.115.4417.0175.597.91
Cash Acquisitions
--1,972-485.25-20-1,174
Investment in Securities
991-926.82-14.3-132.163,011
Other Investing Activities
119.294.4882.0778.62113.9
Investing Cash Flow
-1,775-4,878-2,257-1,3301,246

Financing Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Long-Term Debt Issued
1,2872,2212,900554.341,949
Total Debt Issued
1,2872,2212,900554.341,949
Long-Term Debt Repaid
-1,656-1,037-1,967-1,008-3,777
Total Debt Repaid
-1,656-1,037-1,967-1,008-3,777
Net Debt Issued (Repaid)
-369.61,184933.3-453.42-1,828
Issuance of Common Stock
4,48915.5819.498.861,322
Other Financing Activities
-1,712-1,624-1,593-956.11-1,042
Financing Cash Flow
2,407-424.38-640.16-1,401-1,549

Net Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Net Cash Flow
4,103-2,131-51.64-215.081,898

Free Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Free Cash Flow
5501,082988.991,1841,489
Free Cash Flow Growth
-49.19%9.45%-16.44%-20.51%74.97%
Free Cash Flow Margin
2.16%4.87%5.17%6.98%10.65%
Free Cash Flow Per Share
3.847.657.048.4711.01
Levered Free Cash Flow
-1,225-139.28689.48794.841,400
Unlevered Free Cash Flow
-121.45762.611,3021,3601,919

Additional Metrics

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash Interest Paid
1,6701,5821,171956.11932.62
Cash Income Tax Paid
318.2318.82473.68227.15237.02
Change in Working Capital
-425.4-764.96-271.88-458.68-105.2